Clinical Trials
2 trialsNCT06893354 2025-03-25
Explore the Mechanisms Underlying Disease Resistance and Potential Primary Resistance Mechanism of Induction Therapy Lorlatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Positive Mutation Revealed by Single-cell RNA Sequencing and Spatial Transcriptomics
The First Affiliated Hospital of Guangzhou Medical University
Phase 4 Not yet recruiting
NCT05429515 2022-06-23
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
Peking Union Medical College Hospital
Phase 4 Not yet recruiting